Consequently, these patients often present parkinsonism, dystonia and intellectual disablilities and treatment with the products of TPH2 and TH metabolism, 5-HTP and L-3,4-dihydroxyphenylalanine (L-DOPA), can ameliorate their symptoms15–17. This evidence concerns the gene TH and Parkinsonism.